NCT06485843View on ClinicalTrials.gov

An Study to Evaluate Safety and Tolerability of OA-SYS in Subjects With Moderate to Severe Osteoarthritis of the Knee Joint

PHASE2RecruitingINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

May 21, 2025

Primary Completion Date

March 31, 2028

Study Completion Date

December 31, 2028

Conditions
OsteoarthritisOsteo Arthritis Knee
Interventions
DRUG

OA-SYS

OA-SYS is made of several types of cells obtained from fat tissue for the treatment of osteoarthritis.

Trial Locations (1)

89117

RECRUITING

Orthopedic & Sports Medicine Institute of Las Vegas, Las Vegas

Sponsors
All Listed Sponsors
lead

Ageless Biotech, Inc.

INDUSTRY

NCT06485843 - An Study to Evaluate Safety and Tolerability of OA-SYS in Subjects With Moderate to Severe Osteoarthritis of the Knee Joint | Biotech Hunter | Biotech Hunter